Clincosm LogoSign in Get a demo

Primary Peritoneal Cavity Cancer

Showing 1 - 25 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Orange, California
  • +6 more
Jan 23, 2023

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • NY-ESO-1 peptide vaccine
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

Not yet recruiting
  • Neoplasm, Ovarian
  • +7 more
  • AVB-001 (Dose Escalation Phase)
  • AVB-001 (Dose Expansion Phase)
  • (no location specified)
Sep 15, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,

Completed
  • Ovarian Cancer
  • +2 more
  • IP FT516
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Apr 12, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, other)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 5, 2021

Colorectal Cancer, Metastatic Cancer, Primary Peritoneal Cavity Cancer Trial in Belgium, France (chemo, fluorouracil, leucovorin

Terminated
  • Colorectal Cancer
  • +2 more
  • Liege, Belgium
  • +17 more
Feb 15, 2021

Colorectal Cancer, Primary Peritoneal Cavity Cancer Trial in Bordeaux (biological, drug, procedure)

Terminated
Has Results
  • Colorectal Cancer
  • Primary Peritoneal Cavity Cancer
  • cetuximab
  • +5 more
  • Bordeaux, France
    Institut Bergonie
Jan 5, 2021

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial (immunological adjuvant OPT-821, polyvalent

Withdrawn
  • Fallopian Tube Cancer
  • +2 more
  • immunological adjuvant OPT-821
  • polyvalent antigen-KLH conjugate vaccine
  • (no location specified)
Feb 20, 2020

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Belgium, Netherlands, Spain (carboplatin,

Unknown status
  • Fallopian Tube Cancer
  • +2 more
  • Brussels, Belgium
  • +8 more
Jan 30, 2020

Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen

Completed
Has Results
  • Fallopian Tube Cancer
  • +4 more
  • tamoxifen citrate
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (bortezomib, laboratory biomarker

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (lapatinib ditosylate, laboratory

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer Trial in Philadelphia

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • +2 more
  • bevacizumab
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (ixabepilone)

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (irofulven)

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma Trial in United States (carboplatin, paclitaxel, docetaxel)

Completed
  • Brenner Tumor
  • +12 more
  • Orange, California
  • +15 more
Jul 19, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,

Completed
  • Brenner Tumor
  • +11 more
  • adjuvant therapy
  • +3 more
  • Orange, California
  • +18 more
Jul 19, 2019

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (enzastaurin HCl)

Completed
Has Results
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • enzastaurin hydrochloride
  • Los Angeles, California
  • +15 more
Mar 8, 2019

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Rochester (biological, genetic, other)

Completed
Has Results
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • carcinoembryonic antigen-expressing measles virus
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Feb 15, 2019

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Baltimore (biological, drug, procedure)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +4 more
  • Baltimore, Maryland
  • +1 more
Feb 4, 2019

Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer Trial in United States (ILX-295501)

Withdrawn
  • Fallopian Tube Cancer
  • +3 more
  • Los Angeles, California
  • +7 more
Sep 16, 2018

Carcinoma of the Appendix, Colorectal Cancer, Primary Peritoneal Cavity Cancer Trial in Winston-Salem (oxaliplatin)

Completed
  • Carcinoma of the Appendix
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Comprehensive Cancer Center
Aug 7, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (topotecan HCl)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • topotecan hydrochloride
  • Hartford, Connecticut
  • +77 more
Jun 27, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (mifepristone)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • Los Angeles, California
  • +21 more
Jun 21, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (filgrastim, pegfilgrastim,

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +3 more
  • Burbank, California
  • +36 more
Jun 21, 2018